iSpecimen Inc. (ISPC) stock
ISPCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 7/3029% below fair value
$0.70−0.01 (-1.82%)
Close on Nov 12, 2026Market cap $1.75MP/E –Yield –
iSpecimen pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
No pe ratio figures for iSpecimen
iSpecimen has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?